MarketResearchNest.com adds “Global Percutaneous Coronary Intervention (PCI) Devices Market 2017-2021” new reports to its research database. The report spread across 111 pages with tables and figures in it.
The analysts forecast the global percutaneous coronary intervention (PCI) devices market to grow at a CAGR of 5.73% during the period 2017-2021.
Percutaneous coronary intervention (PCI) is a non-surgical procedure, in which a catheter is used to place stent to broaden the narrowed coronary arteries. PCI is widely used to treat obstructive coronary heart diseases such as multi-vessel coronary disease (CAD) unstable angina and acute myocardial infraction(AMI) effectively. Many factors contribute to the high incidence of CAD, for instance sedentary lifestyle, diabetes, high blood pressure, and excessive alcohol and tobacco consumption.
Get more details about report at https://www.marketresearchnest.com/global-percutaneous-coronary-intervention-pci-devices-market-2017-2021.html .
Research recognizes the following companies as the key players in the global percutaneous coronary intervention (PCI) devices market: Boston Scientific, Abbott, Medtronic, Cordis, and Terumo Medical.
Other Prominent Vendors in the market are: AMG International, ASAHI INTECC, B. Braun Melsungen, BioSensors, BIOTRONIK, BrosMed Medical, Claret Medical, Comed BV, Contego Medical, Elixir Medical, EPflex Feinwerktechnik, GaltNeedleTech, Lepu Medical, Meril Life Sciences, Merit Medical Systems, optimed Medizinische Instrumente, ORBUSNEICH, Penumbra, RONTIS, SP Medical, STENTYS, and Teleflex.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is technological advances. Over the past few years, PCI market is witnessing many technological advances/improvements, especially to develop next-generation coronary stents, EPDs, coronary guidewires, and PTCA catheters which caters the growing need from the patients and the physicians.”
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=274833 .
According to the report, one driver in the market is high incidence of CAD. CAD is the most common heart disease affecting millions of people globally. It is usually caused due to the plaque build-up on the walls of the arteries that carries blood to heart. Over the time, it completely blocks the blood vessel, thereby causing stroke. The narrowing of the arteries partially or totally is termed as atherosclerosis. The factors contributing to the CAD are sedentary life style, smoking, alcohol, high levels of cholesterol in blood and diabetes.
Further, the report states that one challenge in the market is stringent government regulations. Medical devices regulations must be improved to ensure high quality, efficient; safe technologies reach patients. The growing number and modernization of medical devices have introduced new regulatory challenges. For instance, the regulatory networks in Europe and the US are stringent faces similar challenges to ensure patient safety and efficient devices reach the market. The FDA has tightened the rules for medical device in early 1990.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Inquire before buying this report at https://www.marketresearchnest.com/enquirybuy.php?reportid=274833 .
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.
Mr. Jeet Jain
+1-240-284-8070 / +44-20-3290-4151